ORGS - undecided hereIf it breaks the trend line at 5, we may see resistance test at 6.1 again.
If 5 is not broken, then back to 4.4 support testing.
Looks like 4.4 should not be broken so sooner or later we will see 6.
0%
0%
0%
0%
0%
−0.5189USD
−14.889MUSD
36.025MUSD
28.753M
About Orgenesis Inc.
Sector
Industry
CEO
Vered Caplan
Website
Headquarters
Germantown
Employees
167
Founded
2008
ISIN
US68619K2042
Orgenesis, Inc. is a biotechnology company, which engages in the development, manufacturing, and provision of technologies, and services in the cell and gene therapy industry. It operates through the Morgenesis and Therapies segments. The Morgenesis segment refers to the POCare services. The Therapies segment is involved in therapeutic development operations. The company was founded by Sarah Ferber on June 5, 2008 and is headquartered in Germantown, MD.
BUY ORGS - ORGENESIS INC - STRONG BUY ON WEEKLY CHARTBUY ORGS - ORGENESIS INC - STRONG BUY ON WEEKLY CHART
Orgenesis Inc (ORGS)ORGS carving out a nice wedge here after a multi-month pullback. Yesterday’s price action produced an almost perfect bullish reversal Dragonfly Doji, which is just about to kiss the underside of the wedge resistance line and 50 DMA. Plenty of recent Insider buying activity going on, with short inter
Orgenesis Announces Stock Repurchase Plan of Up to $10 Million!!ORGS: Orgenesis Inc.
2020-05-15 07:30:10
Orgenesis Announces Stock Repurchase Plan of Up to $10 Million
See all ideas
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.
